Wnt5a is considered to have a tumor-suppressive function in neuroblastoma [11], leukemia [12], ductal breast carcinomas [13], ER-positive breast cancer [14], colorectal cancer [15], and thyroid cancer [16]. Here, WNT5A is linked to neoplasm.